T. Rowe Price Associates
ORKA

T. Rowe Price Associates’s Oruka Therapeutics, Inc. Common Stock ORKA Stock Holding History

T. Rowe Price Associates’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$4.61M Sell
410,881
-721
-0.2% -$8.08K ﹤0.01% 1296
2025
Q1 		$4.22M Sell
411,602
-915,291
-69% -$9.39M ﹤0.01% 1298
2024
Q4 		$25.7M Buy
1,326,893
+1,047,245
+374% +$20.3M ﹤0.01% 925
2024
Q3 		$6.86M Buy
+279,648
New +$6.86M ﹤0.01% 1214